Drug Type Small molecule drug |
Synonyms Cholesterol-Conjugated Paclitaxel, Paclitaxel Medium and Long Chain Fat Emulsion Injection, Paclitaxel Medium/Long-chain Fat Emulsion Injection (Cholesterol-Conjugated) |
Target |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HER2-negative breast cancer | Phase 1 | CN | 30 Jul 2024 |